These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8848390)

  • 1. Ventricular fibrillation induction using nonsynchronized low energy external shock during rapid ventricular pacing: method of induction when fibrillation mode of ICD fails.
    Sanders WE; Hamrick GL; Herbst MC; Cascio WE; Simpson RJ; Wharton JM
    Pacing Clin Electrophysiol; 1996 Apr; 19(4 Pt 1):431-6. PubMed ID: 8848390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of noninvasive programmed stimulation for initiating ventricular tachyarrhythmias in patients with third-generation implantable cardioverter defibrillators.
    Kleiman RB; Callans DJ; Hook BG; Marchlinski FE
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1462-8. PubMed ID: 7991416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous T wave shock: a universal method for ventricular fibrillation induction.
    Mazer CD; Greene MB; Misale PS; Newman D; Dorian P
    Pacing Clin Electrophysiol; 1997 Dec; 20(12 Pt 1):2930-5. PubMed ID: 9455753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators. Prospective comparison of different lead system-device combinations.
    Natale A; Sra J; Axtell K; Akhtar M; Newby K; Kent V; Geiger MJ; Brandon MJ; Kearney MM; Pacifico A
    Circulation; 1996 Jan; 93(1):91-8. PubMed ID: 8616948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of the new cardioverter defibrillator systems.
    Trappe HJ; Klein H; Fieguth HG; Kielblock B; Wenzlaff P; Lichtlen PR
    Pacing Clin Electrophysiol; 1993 Jan; 16(1 Pt 2):153-8. PubMed ID: 7681563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational registry on efficacy and safety of the right ventricular outflow tract as a site for ICD leads: results of the EFFORT (EFFicacy Of Right ventricular outflow Tract as site for ICD leads) registry.
    Mascioli G; Gelmini G; Reggiani A; Giudici V; Spotti A; Mocini A; Marconi R; Ruffa F; Zanotto G
    J Interv Card Electrophysiol; 2010 Sep; 28(3):215-20. PubMed ID: 20577792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
    Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
    Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with an implantable cardioverter defibrillator for spontaneous ventricular fibrillation in dilated cardiomyopathy with very high defibrillation thresholds.
    Tamura K; Abe H; Nagatomo T; Nakashima Y
    J UOEH; 2001 Dec; 23(4):363-8. PubMed ID: 11789138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with a third-generation implantable cardioverter-defibrillator.
    Saksena S; Mehta D; Krol RB; Tullo NG; Saxena A; Kaushik R; Neglia J
    Am J Cardiol; 1991 Jun; 67(16):1375-84. PubMed ID: 2042568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and diagnostic yield of noninvasive ventricular stimulation performed via tiered therapy implantable defibrillators.
    Pinski SL; Shewchick J; Tobin M; Castle LW
    Pacing Clin Electrophysiol; 1994 Dec; 17(12 Pt 1):2263-73. PubMed ID: 7885933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pacing induced ventricular fibrillation in internal cardioverter defibrillator patients: a new form of proarrhythmia.
    Vlay LC; Vlay SC
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):132-3. PubMed ID: 9121960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.
    Doyle CL; Huang DT; Moss AJ; Solomon SD; Campbell P; McNitt S; Polonsky S; Barsheshet A; Aktas M; Tompkins C; Zareba W; Goldenberg I
    Heart Rhythm; 2013 Oct; 10(10):1471-7. PubMed ID: 23872690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of ventricular arrhythmias induced with programmed stimulation versus alternating current.
    Cua M; Veltri EP
    Pacing Clin Electrophysiol; 1993 Mar; 16(3 Pt 1):382-6. PubMed ID: 7681187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.